

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 5.70155340 |
| 2 | actin-myosin filament sliding (GO:0033275) | 5.54461043 |
| 3 | muscle filament sliding (GO:0030049) | 5.54461043 |
| 4 | plasma membrane repair (GO:0001778) | 5.27258239 |
| 5 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.17955516 |
| 6 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.87457062 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 4.80534436 |
| 8 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.59899762 |
| 9 | actin-mediated cell contraction (GO:0070252) | 4.59796590 |
| 10 | cardiac myofibril assembly (GO:0055003) | 4.31803726 |
| 11 | myofibril assembly (GO:0030239) | 4.31235371 |
| 12 | regulation of vitamin metabolic process (GO:0030656) | 4.26600819 |
| 13 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.15168161 |
| 14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.08490490 |
| 15 | skeletal muscle adaptation (GO:0043501) | 4.04205249 |
| 16 | activation of MAPKKK activity (GO:0000185) | 3.99882209 |
| 17 | cardiac muscle cell development (GO:0055013) | 3.91467015 |
| 18 | epithelial cell-cell adhesion (GO:0090136) | 3.80187199 |
| 19 | actomyosin structure organization (GO:0031032) | 3.73757380 |
| 20 | virion attachment to host cell (GO:0019062) | 3.73348885 |
| 21 | adhesion of symbiont to host cell (GO:0044650) | 3.73348885 |
| 22 | cardiac cell development (GO:0055006) | 3.72313991 |
| 23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.68033535 |
| 24 | regulation of podosome assembly (GO:0071801) | 3.62618359 |
| 25 | actin filament-based movement (GO:0030048) | 3.60621908 |
| 26 | regulation of chronic inflammatory response (GO:0002676) | 3.60127526 |
| 27 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.58719780 |
| 28 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.54446532 |
| 29 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.50741976 |
| 30 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.49432047 |
| 31 | adhesion of symbiont to host (GO:0044406) | 3.49083865 |
| 32 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.47213280 |
| 33 | tricarboxylic acid cycle (GO:0006099) | 3.44353800 |
| 34 | NIK/NF-kappaB signaling (GO:0038061) | 3.37741058 |
| 35 | protein localization to endosome (GO:0036010) | 3.35854369 |
| 36 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.32380522 |
| 37 | positive regulation of heat generation (GO:0031652) | 3.27582890 |
| 38 | striated muscle atrophy (GO:0014891) | 3.25018622 |
| 39 | carnitine shuttle (GO:0006853) | 3.23439994 |
| 40 | apoptotic process involved in morphogenesis (GO:0060561) | 3.20954795 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.20878776 |
| 42 | regulation of chemokine biosynthetic process (GO:0045073) | 3.20169945 |
| 43 | skeletal muscle contraction (GO:0003009) | 3.18368492 |
| 44 | regulation of gene silencing by RNA (GO:0060966) | 3.16337830 |
| 45 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.16337830 |
| 46 | regulation of gene silencing by miRNA (GO:0060964) | 3.16337830 |
| 47 | IMP metabolic process (GO:0046040) | 3.15167966 |
| 48 | IMP biosynthetic process (GO:0006188) | 3.13860958 |
| 49 | pinocytosis (GO:0006907) | 3.11818445 |
| 50 | regulation of fever generation (GO:0031620) | 3.11562493 |
| 51 | paraxial mesoderm development (GO:0048339) | 3.09203723 |
| 52 | heart trabecula formation (GO:0060347) | 3.09052851 |
| 53 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.08774399 |
| 54 | barbed-end actin filament capping (GO:0051016) | 3.06212772 |
| 55 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.05748241 |
| 56 | cell-substrate junction assembly (GO:0007044) | 3.04318383 |
| 57 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.01329175 |
| 58 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.99053809 |
| 59 | regulation of early endosome to late endosome transport (GO:2000641) | 2.97790726 |
| 60 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.95917462 |
| 61 | regulation of mononuclear cell migration (GO:0071675) | 2.95516658 |
| 62 | hemidesmosome assembly (GO:0031581) | 2.95474042 |
| 63 | cardiac muscle contraction (GO:0060048) | 2.91716671 |
| 64 | germinal center formation (GO:0002467) | 2.91552715 |
| 65 | cell adhesion mediated by integrin (GO:0033627) | 2.91387489 |
| 66 | myeloid dendritic cell differentiation (GO:0043011) | 2.90105781 |
| 67 | fatty acid transmembrane transport (GO:1902001) | 2.89942945 |
| 68 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87668051 |
| 69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.87498226 |
| 70 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.87284556 |
| 71 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.86792936 |
| 72 | striated muscle contraction (GO:0006941) | 2.86487963 |
| 73 | T-helper 1 type immune response (GO:0042088) | 2.86387739 |
| 74 | regulation of tight junction assembly (GO:2000810) | 2.85136800 |
| 75 | regulation of p38MAPK cascade (GO:1900744) | 2.84704323 |
| 76 | response to muscle activity (GO:0014850) | 2.84517556 |
| 77 | muscle tissue morphogenesis (GO:0060415) | 2.83387726 |
| 78 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.80403213 |
| 79 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.80071196 |
| 80 | regulation of cholesterol storage (GO:0010885) | 2.79520580 |
| 81 | wound healing, spreading of epidermal cells (GO:0035313) | 2.76898983 |
| 82 | regulation of interferon-alpha production (GO:0032647) | 2.76630685 |
| 83 | desmosome organization (GO:0002934) | 2.75711297 |
| 84 | creatine metabolic process (GO:0006600) | 2.74228217 |
| 85 | glycosphingolipid catabolic process (GO:0046479) | 2.73359090 |
| 86 | focal adhesion assembly (GO:0048041) | 2.71889730 |
| 87 | cell-substrate adherens junction assembly (GO:0007045) | 2.71889730 |
| 88 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.71524675 |
| 89 | regulation of hippo signaling (GO:0035330) | 2.71516586 |
| 90 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.71348858 |
| 91 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69696949 |
| 92 | basement membrane organization (GO:0071711) | 2.68652852 |
| 93 | type I interferon signaling pathway (GO:0060337) | 2.68012943 |
| 94 | cellular response to type I interferon (GO:0071357) | 2.68012943 |
| 95 | response to inactivity (GO:0014854) | 2.67783982 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.67260574 |
| 97 | ventricular cardiac muscle cell development (GO:0055015) | 2.66868167 |
| 98 | adherens junction assembly (GO:0034333) | 2.66263742 |
| 99 | stress fiber assembly (GO:0043149) | 2.65839718 |
| 100 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.65412093 |
| 101 | regulation of immunoglobulin secretion (GO:0051023) | 2.65299305 |
| 102 | response to type I interferon (GO:0034340) | 2.64961432 |
| 103 | protein hydroxylation (GO:0018126) | 2.64422179 |
| 104 | decidualization (GO:0046697) | 2.64114731 |
| 105 | response to peptidoglycan (GO:0032494) | 2.60426806 |
| 106 | NADH metabolic process (GO:0006734) | 2.58478681 |
| 107 | regulation of integrin activation (GO:0033623) | 2.56308529 |
| 108 | negative regulation of necroptotic process (GO:0060546) | 2.54608139 |
| 109 | cellular response to virus (GO:0098586) | 2.54226815 |
| 110 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.54100729 |
| 111 | positive regulation of lipid storage (GO:0010884) | 2.53983418 |
| 112 | negative regulation of lipid storage (GO:0010888) | 2.52766283 |
| 113 | regulation of actin filament-based movement (GO:1903115) | 2.51782815 |
| 114 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.51031270 |
| 115 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.50929249 |
| 116 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.50393969 |
| 117 | oligosaccharide catabolic process (GO:0009313) | 2.50220946 |
| 118 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.49828565 |
| 119 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.49637825 |
| 120 | modulation by symbiont of host cellular process (GO:0044068) | 2.49190969 |
| 121 | protein heterotrimerization (GO:0070208) | 2.49144023 |
| 122 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.48489760 |
| 123 | negative regulation of interleukin-12 production (GO:0032695) | 2.48285347 |
| 124 | endocytic recycling (GO:0032456) | 2.46860995 |
| 125 | negative regulation of cell size (GO:0045792) | 2.46832624 |
| 126 | skeletal muscle tissue regeneration (GO:0043403) | 2.46662106 |
| 127 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.46497270 |
| 128 | positive regulation of myotube differentiation (GO:0010831) | 2.45948037 |
| 129 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.45931684 |
| 130 | low-density lipoprotein particle clearance (GO:0034383) | 2.45121952 |
| 131 | striated muscle cell development (GO:0055002) | 2.44912730 |
| 132 | positive regulation of p38MAPK cascade (GO:1900745) | 2.43994823 |
| 133 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.43154836 |
| 134 | regulation of relaxation of muscle (GO:1901077) | 2.43092105 |
| 135 | muscle atrophy (GO:0014889) | 2.42256425 |
| 136 | fructose metabolic process (GO:0006000) | 2.41378420 |
| 137 | trophoblast giant cell differentiation (GO:0060707) | 2.41285345 |
| 138 | peptidyl-proline hydroxylation (GO:0019511) | 2.40754305 |
| 139 | regulation of coenzyme metabolic process (GO:0051196) | 2.40187373 |
| 140 | regulation of cofactor metabolic process (GO:0051193) | 2.40187373 |
| 141 | endodermal cell differentiation (GO:0035987) | 2.40131178 |
| 142 | cellular response to lipopolysaccharide (GO:0071222) | 2.39897499 |
| 143 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.39789685 |
| 144 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.38559023 |
| 145 | cellular response to nicotine (GO:0071316) | 2.38480662 |
| 146 | chronic inflammatory response (GO:0002544) | 2.38415601 |
| 147 | glycolipid catabolic process (GO:0019377) | 2.37979760 |
| 148 | maternal placenta development (GO:0001893) | 2.36444791 |
| 149 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.35905479 |
| 150 | apoptotic cell clearance (GO:0043277) | 2.35631507 |
| 151 | mRNA transcription (GO:0009299) | 2.35564362 |
| 152 | heart process (GO:0003015) | 2.35211659 |
| 153 | heart contraction (GO:0060047) | 2.35211659 |
| 154 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.34956824 |
| 155 | negative regulation of heart growth (GO:0061117) | 2.34944537 |
| 156 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.34944537 |
| 157 | striated muscle adaptation (GO:0014888) | 2.34448531 |
| 158 | muscle contraction (GO:0006936) | 2.34126447 |
| 159 | trabecula morphogenesis (GO:0061383) | 2.34056960 |
| 160 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.34047386 |
| 161 | establishment of endothelial barrier (GO:0061028) | 2.33962079 |
| 162 | response to activity (GO:0014823) | 2.33690785 |
| 163 | skin morphogenesis (GO:0043589) | 2.33650142 |
| 164 | establishment of apical/basal cell polarity (GO:0035089) | 2.33282649 |
| 165 | COPI coating of Golgi vesicle (GO:0048205) | 2.33148777 |
| 166 | Golgi transport vesicle coating (GO:0048200) | 2.33148777 |
| 167 | regulation of sequestering of triglyceride (GO:0010889) | 2.31795952 |
| 168 | apoptotic process involved in development (GO:1902742) | 2.31710873 |
| 169 | oxidative phosphorylation (GO:0006119) | 2.31180830 |
| 170 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.30922468 |
| 171 | endothelial tube morphogenesis (GO:0061154) | 2.30019285 |
| 172 | morphogenesis of an endothelium (GO:0003159) | 2.30019285 |
| 173 | heterochromatin organization (GO:0070828) | 2.29410973 |
| 174 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.29026553 |
| 175 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.27133452 |
| 176 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.26793992 |
| 177 | polarized epithelial cell differentiation (GO:0030859) | 2.25988460 |
| 178 | hippo signaling (GO:0035329) | 2.25606918 |
| 179 | regulation of translational fidelity (GO:0006450) | 2.25116998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.49559042 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.71123870 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.03449037 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.86631342 |
| 5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62360424 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.57178194 |
| 7 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.34035436 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.30682435 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30251375 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28914510 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.27998414 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15223473 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.13614317 |
| 14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.01100827 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00713340 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.00196825 |
| 17 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.98145750 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89358951 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79143942 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.76999554 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76889590 |
| 22 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.75640081 |
| 23 | ATF3_27146783_Chip-Seq_COLON_Human | 1.74947902 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.72930618 |
| 25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.72310633 |
| 26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.72310633 |
| 27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.72310633 |
| 28 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66096601 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64533311 |
| 30 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63049964 |
| 31 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60127377 |
| 32 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.59976766 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59850094 |
| 34 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.58932430 |
| 35 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.56362816 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55710903 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53555540 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.50486283 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48895388 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.43415147 |
| 41 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.42696711 |
| 42 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.42696711 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.42073298 |
| 44 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.41193347 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40427864 |
| 46 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.39558883 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37470182 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37445183 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37251216 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36161659 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36134146 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36097957 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34374929 |
| 54 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34127588 |
| 55 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.33710137 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.33090418 |
| 57 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32888719 |
| 58 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.32843614 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29909642 |
| 60 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.29629934 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29034168 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27922373 |
| 63 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26968226 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26903323 |
| 65 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23779035 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23426529 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22570717 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22412170 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22186859 |
| 70 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.21368958 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21365977 |
| 72 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21176586 |
| 73 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.20543791 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20044925 |
| 75 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19111051 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18388870 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17749880 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17237097 |
| 79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16749284 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16675718 |
| 81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16675718 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16638423 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16254935 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15820155 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14104217 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13756689 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11866655 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11645164 |
| 89 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10819635 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10744595 |
| 91 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09998606 |
| 92 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09849218 |
| 93 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09580029 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08938079 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08748394 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08201871 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07732415 |
| 98 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06771129 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06619506 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06530668 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06514373 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06482501 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06270344 |
| 104 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.05956492 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05596344 |
| 106 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05180315 |
| 107 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04917904 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04562588 |
| 109 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03834356 |
| 110 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02549639 |
| 111 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01870765 |
| 112 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01291288 |
| 113 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.00498824 |
| 114 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00291549 |
| 115 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.00265197 |
| 116 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99254314 |
| 117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99235758 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98483714 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97505744 |
| 120 | MAF_26560356_Chip-Seq_TH1_Human | 0.97102584 |
| 121 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96610080 |
| 122 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.94762933 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94470881 |
| 124 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93898991 |
| 125 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93389482 |
| 126 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93257687 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93134634 |
| 128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92396498 |
| 129 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.92264764 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91897666 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91889980 |
| 132 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.91778894 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91731050 |
| 134 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.91713439 |
| 135 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91701758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.74576739 |
| 2 | MP0005451_abnormal_body_composition | 3.74037238 |
| 3 | MP0000751_myopathy | 3.27951692 |
| 4 | MP0003646_muscle_fatigue | 3.26681129 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.10478888 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.09848048 |
| 7 | MP0000749_muscle_degeneration | 2.99816919 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.98658533 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.95896347 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.87393120 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.74192806 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.38554137 |
| 13 | MP0005330_cardiomyopathy | 2.36040584 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.31324895 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.30438656 |
| 16 | MP0002254_reproductive_system_inflammat | 2.25477769 |
| 17 | MP0005275_abnormal_skin_tensile | 2.17106881 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.08251506 |
| 19 | MP0002269_muscular_atrophy | 2.06400230 |
| 20 | MP0002106_abnormal_muscle_physiology | 1.99164015 |
| 21 | MP0010630_abnormal_cardiac_muscle | 1.88252064 |
| 22 | MP0003828_pulmonary_edema | 1.84389542 |
| 23 | MP0000759_abnormal_skeletal_muscle | 1.84322364 |
| 24 | MP0004215_abnormal_myocardial_fiber | 1.77443612 |
| 25 | MP0004145_abnormal_muscle_electrophysio | 1.75808657 |
| 26 | MP0003436_decreased_susceptibility_to | 1.72882622 |
| 27 | MP0000733_abnormal_muscle_development | 1.72021516 |
| 28 | MP0009785_altered_susceptibility_to | 1.67223367 |
| 29 | MP0004272_abnormal_basement_membrane | 1.66975965 |
| 30 | * MP0002148_abnormal_hypersensitivity_rea | 1.65975355 |
| 31 | MP0005369_muscle_phenotype | 1.63760124 |
| 32 | MP0005620_abnormal_muscle_contractility | 1.62937838 |
| 33 | MP0004130_abnormal_muscle_cell | 1.61501521 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.60738490 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 1.59985368 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.59985368 |
| 37 | MP0008004_abnormal_stomach_pH | 1.58131324 |
| 38 | MP0004233_abnormal_muscle_weight | 1.57370713 |
| 39 | MP0000747_muscle_weakness | 1.57363487 |
| 40 | MP0002972_abnormal_cardiac_muscle | 1.56353689 |
| 41 | MP0004947_skin_inflammation | 1.54689023 |
| 42 | MP0006082_CNS_inflammation | 1.54112927 |
| 43 | MP0003075_altered_response_to | 1.51706843 |
| 44 | MP0003279_aneurysm | 1.51391292 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.48696873 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.48619334 |
| 47 | MP0010030_abnormal_orbit_morphology | 1.44311961 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.42782475 |
| 49 | MP0003941_abnormal_skin_development | 1.37395776 |
| 50 | MP0006138_congestive_heart_failure | 1.35718265 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.35653610 |
| 52 | MP0005023_abnormal_wound_healing | 1.34375577 |
| 53 | MP0000858_altered_metastatic_potential | 1.34243201 |
| 54 | MP0001853_heart_inflammation | 1.29049641 |
| 55 | MP0003567_abnormal_fetal_cardiomyocyte | 1.27544963 |
| 56 | * MP0005666_abnormal_adipose_tissue | 1.26350113 |
| 57 | MP0000343_altered_response_to | 1.25770093 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.25117006 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.24717083 |
| 60 | MP0005670_abnormal_white_adipose | 1.23556946 |
| 61 | MP0003724_increased_susceptibility_to | 1.23024994 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.22459337 |
| 63 | MP0001958_emphysema | 1.21368417 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.19490307 |
| 65 | MP0005387_immune_system_phenotype | 1.17003713 |
| 66 | MP0001790_abnormal_immune_system | 1.17003713 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.16620188 |
| 68 | MP0005503_abnormal_tendon_morphology | 1.16502755 |
| 69 | MP0004510_myositis | 1.14142252 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.12815485 |
| 71 | MP0009764_decreased_sensitivity_to | 1.08907114 |
| 72 | MP0003950_abnormal_plasma_membrane | 1.06372315 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.06154944 |
| 74 | MP0003137_abnormal_impulse_conducting | 1.05832457 |
| 75 | MP0001849_ear_inflammation | 1.05668720 |
| 76 | MP0004858_abnormal_nervous_system | 1.05460243 |
| 77 | MP0004957_abnormal_blastocyst_morpholog | 1.04998381 |
| 78 | MP0000003_abnormal_adipose_tissue | 1.04981017 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 1.04791814 |
| 80 | MP0005166_decreased_susceptibility_to | 1.04413704 |
| 81 | MP0000266_abnormal_heart_morphology | 1.04191785 |
| 82 | MP0004484_altered_response_of | 1.03444554 |
| 83 | MP0003984_embryonic_growth_retardation | 1.03215144 |
| 84 | MP0001542_abnormal_bone_strength | 1.02877642 |
| 85 | MP0005000_abnormal_immune_tolerance | 1.02868985 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 1.02499749 |
| 87 | MP0002108_abnormal_muscle_morphology | 1.02221143 |
| 88 | MP0002127_abnormal_cardiovascular_syste | 1.01667568 |
| 89 | MP0002060_abnormal_skin_morphology | 1.00134224 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.99482153 |
| 91 | MP0005025_abnormal_response_to | 0.97447914 |
| 92 | MP0005380_embryogenesis_phenotype | 0.95109645 |
| 93 | MP0001672_abnormal_embryogenesis/_devel | 0.95109645 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.94294208 |
| 95 | * MP0004185_abnormal_adipocyte_glucose | 0.94117558 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.93702132 |
| 97 | MP0002419_abnormal_innate_immunity | 0.92179567 |
| 98 | MP0001730_embryonic_growth_arrest | 0.91927087 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.91191825 |
| 100 | MP0003091_abnormal_cell_migration | 0.90773575 |
| 101 | * MP0005375_adipose_tissue_phenotype | 0.90161275 |
| 102 | MP0008260_abnormal_autophagy | 0.90046872 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.89227983 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.88367304 |
| 105 | MP0002796_impaired_skin_barrier | 0.86692715 |
| 106 | MP0002128_abnormal_blood_circulation | 0.85977672 |
| 107 | MP0009278_abnormal_bone_marrow | 0.85716858 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.85435043 |
| 109 | MP0002925_abnormal_cardiovascular_devel | 0.84927594 |
| 110 | MP0000013_abnormal_adipose_tissue | 0.82812645 |
| 111 | MP0002086_abnormal_extraembryonic_tissu | 0.82715717 |
| 112 | MP0008469_abnormal_protein_level | 0.80885463 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.80724262 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.80689995 |
| 115 | MP0003693_abnormal_embryo_hatching | 0.78688752 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.78456710 |
| 117 | MP0002933_joint_inflammation | 0.77666805 |
| 118 | MP0001697_abnormal_embryo_size | 0.77284474 |
| 119 | MP0005165_increased_susceptibility_to | 0.76737450 |
| 120 | MP0001614_abnormal_blood_vessel | 0.76618784 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.76285279 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.76172676 |
| 123 | MP0005164_abnormal_response_to | 0.75915346 |
| 124 | MP0010307_abnormal_tumor_latency | 0.73949459 |
| 125 | MP0005501_abnormal_skin_physiology | 0.73865972 |
| 126 | MP0005257_abnormal_intraocular_pressure | 0.73676509 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.73675017 |
| 128 | MP0009840_abnormal_foam_cell | 0.73668321 |
| 129 | MP0001243_abnormal_dermal_layer | 0.71348024 |
| 130 | MP0005508_abnormal_skeleton_morphology | 0.70846530 |
| 131 | MP0000350_abnormal_cell_proliferation | 0.70835615 |
| 132 | MP0005266_abnormal_metabolism | 0.70412044 |
| 133 | MP0003077_abnormal_cell_cycle | 0.70349230 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.68708527 |
| 135 | MP0002085_abnormal_embryonic_tissue | 0.68243340 |
| 136 | MP0006054_spinal_hemorrhage | 0.67148102 |
| 137 | MP0003448_altered_tumor_morphology | 0.66001144 |
| 138 | MP0002080_prenatal_lethality | 0.65849175 |
| 139 | MP0009053_abnormal_anal_canal | 0.65266568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased connective tissue (HP:0009025) | 5.76406549 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.28596378 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.15514980 |
| 4 | Ventricular tachycardia (HP:0004756) | 4.56261037 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 4.55861218 |
| 6 | Exercise-induced myalgia (HP:0003738) | 4.42359549 |
| 7 | Sudden death (HP:0001699) | 4.39073341 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 4.34059753 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.25993346 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.19656035 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 4.19354999 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 4.07969805 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.05713399 |
| 14 | Myoglobinuria (HP:0002913) | 3.94490498 |
| 15 | Difficulty climbing stairs (HP:0003551) | 3.90652725 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.76544780 |
| 17 | Difficulty running (HP:0009046) | 3.73629378 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.69188150 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.69188150 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.69188150 |
| 21 | Distal lower limb muscle weakness (HP:0009053) | 3.62718280 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.61973818 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 3.61488625 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.59744659 |
| 25 | Nemaline bodies (HP:0003798) | 3.58286250 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.55062887 |
| 27 | Premature rupture of membranes (HP:0001788) | 3.46040487 |
| 28 | Lipoatrophy (HP:0100578) | 3.41767157 |
| 29 | Nuclear cataract (HP:0100018) | 3.29353415 |
| 30 | Round ear (HP:0100830) | 3.24087914 |
| 31 | Subaortic stenosis (HP:0001682) | 3.06703966 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.06703966 |
| 33 | Axonal loss (HP:0003447) | 3.00161527 |
| 34 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.97408436 |
| 35 | Distal arthrogryposis (HP:0005684) | 2.97083029 |
| 36 | Spinal rigidity (HP:0003306) | 2.97048585 |
| 37 | Myopathic facies (HP:0002058) | 2.96339298 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.91714399 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 2.85453661 |
| 40 | Ankle contracture (HP:0006466) | 2.83159499 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 2.82563615 |
| 42 | Ulnar deviation of the wrist (HP:0003049) | 2.79545097 |
| 43 | Myotonia (HP:0002486) | 2.78941693 |
| 44 | Atrial fibrillation (HP:0005110) | 2.76253884 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.66164945 |
| 46 | Dilated cardiomyopathy (HP:0001644) | 2.65561110 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 2.65486927 |
| 48 | Calcaneovalgus deformity (HP:0001848) | 2.62993984 |
| 49 | Muscle stiffness (HP:0003552) | 2.62976010 |
| 50 | Cerebral aneurysm (HP:0004944) | 2.61491726 |
| 51 | Primary atrial arrhythmia (HP:0001692) | 2.57519937 |
| 52 | Supraventricular arrhythmia (HP:0005115) | 2.55570801 |
| 53 | Areflexia of lower limbs (HP:0002522) | 2.54982177 |
| 54 | Supraventricular tachycardia (HP:0004755) | 2.51325050 |
| 55 | Bulbar palsy (HP:0001283) | 2.51227220 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.50774266 |
| 57 | Neck muscle weakness (HP:0000467) | 2.46159601 |
| 58 | Palpitations (HP:0001962) | 2.37705655 |
| 59 | Deformed tarsal bones (HP:0008119) | 2.35302848 |
| 60 | Testicular atrophy (HP:0000029) | 2.32162883 |
| 61 | Scapular winging (HP:0003691) | 2.32056432 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.31594979 |
| 63 | Abnormality of the calcaneus (HP:0008364) | 2.28134112 |
| 64 | Loss of speech (HP:0002371) | 2.21575660 |
| 65 | Broad metatarsal (HP:0001783) | 2.16433698 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.16162524 |
| 67 | Shallow orbits (HP:0000586) | 2.15714337 |
| 68 | Atrophic scars (HP:0001075) | 2.15688414 |
| 69 | Achilles tendon contracture (HP:0001771) | 2.15405054 |
| 70 | Myocardial infarction (HP:0001658) | 2.15306166 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 2.10069299 |
| 72 | Multiple enchondromatosis (HP:0005701) | 2.08285875 |
| 73 | Ventricular arrhythmia (HP:0004308) | 2.05327565 |
| 74 | Ragged-red muscle fibers (HP:0003200) | 2.05175217 |
| 75 | Malignant hyperthermia (HP:0002047) | 2.04146590 |
| 76 | Wrist flexion contracture (HP:0001239) | 2.03653799 |
| 77 | Generalized amyotrophy (HP:0003700) | 2.03444428 |
| 78 | Abnormal atrioventricular conduction (HP:0005150) | 2.01275187 |
| 79 | Limb-girdle muscle weakness (HP:0003325) | 2.01023709 |
| 80 | Bundle branch block (HP:0011710) | 2.00833525 |
| 81 | Frequent falls (HP:0002359) | 2.00288974 |
| 82 | Muscular dystrophy (HP:0003560) | 1.96768787 |
| 83 | Hypoplastic ischia (HP:0003175) | 1.96547076 |
| 84 | Generalized muscle weakness (HP:0003324) | 1.95586498 |
| 85 | Rectal prolapse (HP:0002035) | 1.94377311 |
| 86 | Trismus (HP:0000211) | 1.94346064 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 1.89764172 |
| 88 | Aortic dissection (HP:0002647) | 1.87440918 |
| 89 | Progressive muscle weakness (HP:0003323) | 1.86924885 |
| 90 | Increased density of long bones (HP:0006392) | 1.86659459 |
| 91 | Neurofibrillary tangles (HP:0002185) | 1.85946755 |
| 92 | Slender build (HP:0001533) | 1.84153621 |
| 93 | EMG: neuropathic changes (HP:0003445) | 1.83995947 |
| 94 | Facial diplegia (HP:0001349) | 1.83827848 |
| 95 | Thin bony cortex (HP:0002753) | 1.81038318 |
| 96 | Aneurysm (HP:0002617) | 1.80697308 |
| 97 | Absent phalangeal crease (HP:0006109) | 1.80503096 |
| 98 | Soft skin (HP:0000977) | 1.78998525 |
| 99 | Increased serum ferritin (HP:0003281) | 1.78960920 |
| 100 | Fragile skin (HP:0001030) | 1.77926249 |
| 101 | Atrioventricular block (HP:0001678) | 1.77606005 |
| 102 | Glomerulonephritis (HP:0000099) | 1.76868102 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76028011 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76028011 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76028011 |
| 106 | Abnormality of complement system (HP:0005339) | 1.75772015 |
| 107 | Heart block (HP:0012722) | 1.75199239 |
| 108 | Hip contracture (HP:0003273) | 1.74247722 |
| 109 | Increased cerebral lipofuscin (HP:0011813) | 1.72753822 |
| 110 | Cervical subluxation (HP:0003308) | 1.71791517 |
| 111 | Mesangial abnormality (HP:0001966) | 1.70373915 |
| 112 | Osteolytic defects of the hand bones (HP:0009699) | 1.70261568 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70261568 |
| 114 | Aortic aneurysm (HP:0004942) | 1.69591388 |
| 115 | Distal upper limb amyotrophy (HP:0007149) | 1.69228140 |
| 116 | Upper limb amyotrophy (HP:0009129) | 1.69228140 |
| 117 | Abnormality of the ischium (HP:0003174) | 1.68812473 |
| 118 | Hyperacusis (HP:0010780) | 1.68580854 |
| 119 | Lower limb amyotrophy (HP:0007210) | 1.68035811 |
| 120 | Disinhibition (HP:0000734) | 1.67189296 |
| 121 | Polycythemia (HP:0001901) | 1.66941488 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.66842490 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.66842490 |
| 124 | Cerebral inclusion bodies (HP:0100314) | 1.66563893 |
| 125 | Syncope (HP:0001279) | 1.66379430 |
| 126 | Foot dorsiflexor weakness (HP:0009027) | 1.66065483 |
| 127 | Pelvic girdle muscle weakness (HP:0003749) | 1.65662752 |
| 128 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65502953 |
| 129 | Peritonitis (HP:0002586) | 1.64741880 |
| 130 | Rimmed vacuoles (HP:0003805) | 1.64043480 |
| 131 | Breech presentation (HP:0001623) | 1.63984211 |
| 132 | Shoulder girdle muscle weakness (HP:0003547) | 1.63017022 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.62999934 |
| 134 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.62803031 |
| 135 | Abnormality of macrophages (HP:0004311) | 1.62482439 |
| 136 | Proximal amyotrophy (HP:0007126) | 1.62375252 |
| 137 | Complement deficiency (HP:0004431) | 1.60012684 |
| 138 | Natal tooth (HP:0000695) | 1.58198048 |
| 139 | Selective tooth agenesis (HP:0001592) | 1.57773155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.58199347 |
| 2 | IRAK3 | 4.67084198 |
| 3 | TRIB3 | 3.38144496 |
| 4 | PKN2 | 2.91267372 |
| 5 | OBSCN | 2.82161472 |
| 6 | EPHA2 | 2.59070818 |
| 7 | NEK1 | 2.41307743 |
| 8 | PRPF4B | 2.14388816 |
| 9 | DMPK | 2.11146680 |
| 10 | MOS | 2.03865624 |
| 11 | MAP3K14 | 1.98710191 |
| 12 | PHKG1 | 1.94517700 |
| 13 | PHKG2 | 1.94517700 |
| 14 | PDK4 | 1.72748194 |
| 15 | PDK3 | 1.72748194 |
| 16 | ERN1 | 1.71351494 |
| 17 | MAPKAPK3 | 1.67237311 |
| 18 | CDC42BPA | 1.66981006 |
| 19 | BCKDK | 1.66963327 |
| 20 | MAP2K3 | 1.66621628 |
| 21 | PAK4 | 1.66428687 |
| 22 | RIPK1 | 1.65718895 |
| 23 | MYLK | 1.62177409 |
| 24 | LATS2 | 1.56612140 |
| 25 | MAP3K3 | 1.52625887 |
| 26 | PDGFRA | 1.52078203 |
| 27 | GRK7 | 1.50162602 |
| 28 | PIK3CA | 1.50031319 |
| 29 | SMG1 | 1.44403136 |
| 30 | RPS6KB2 | 1.41720585 |
| 31 | DDR2 | 1.40648583 |
| 32 | LMTK2 | 1.40614312 |
| 33 | TIE1 | 1.38697428 |
| 34 | PDK2 | 1.33515482 |
| 35 | FLT3 | 1.29769028 |
| 36 | STK38L | 1.27116172 |
| 37 | EEF2K | 1.25537089 |
| 38 | KDR | 1.23679815 |
| 39 | LATS1 | 1.23038252 |
| 40 | BUB1 | 1.21639349 |
| 41 | ARAF | 1.20442250 |
| 42 | LRRK2 | 1.18752080 |
| 43 | MAP3K10 | 1.18572761 |
| 44 | NEK9 | 1.17955733 |
| 45 | MAP3K11 | 1.14957103 |
| 46 | STK10 | 1.10986567 |
| 47 | BMX | 1.10535903 |
| 48 | PTK6 | 1.08892959 |
| 49 | TRPM7 | 1.06711244 |
| 50 | ABL2 | 1.05357919 |
| 51 | TGFBR1 | 1.03002642 |
| 52 | NME2 | 1.02771661 |
| 53 | MAP3K13 | 1.02338756 |
| 54 | RPS6KA4 | 1.00655554 |
| 55 | FER | 1.00395384 |
| 56 | CDK12 | 1.00154067 |
| 57 | TGFBR2 | 0.99875470 |
| 58 | ILK | 0.99599396 |
| 59 | MATK | 0.97611391 |
| 60 | IKBKB | 0.93436417 |
| 61 | MAP3K8 | 0.91786470 |
| 62 | EPHB2 | 0.85392484 |
| 63 | MAP3K1 | 0.85007639 |
| 64 | SIK1 | 0.83992758 |
| 65 | PIM2 | 0.83701902 |
| 66 | NME1 | 0.83672173 |
| 67 | EIF2AK1 | 0.82043220 |
| 68 | EPHB1 | 0.81275028 |
| 69 | PIK3CG | 0.81250872 |
| 70 | WEE1 | 0.80027588 |
| 71 | TBK1 | 0.79167239 |
| 72 | TTK | 0.78910407 |
| 73 | TESK1 | 0.76162674 |
| 74 | MTOR | 0.76084385 |
| 75 | MAP3K7 | 0.72642817 |
| 76 | FGR | 0.71503813 |
| 77 | ZAK | 0.69951970 |
| 78 | PAK2 | 0.68972335 |
| 79 | PTK2 | 0.68342516 |
| 80 | IRAK4 | 0.67373500 |
| 81 | JAK3 | 0.65831517 |
| 82 | NEK2 | 0.64511217 |
| 83 | STK4 | 0.64282386 |
| 84 | DAPK3 | 0.64210177 |
| 85 | FGFR4 | 0.63259873 |
| 86 | STK3 | 0.61403836 |
| 87 | IKBKE | 0.60915570 |
| 88 | BRAF | 0.60895362 |
| 89 | PRKD1 | 0.59864082 |
| 90 | IRAK2 | 0.57530353 |
| 91 | CLK1 | 0.57078199 |
| 92 | AKT2 | 0.56350521 |
| 93 | ERBB4 | 0.55585337 |
| 94 | MET | 0.55406307 |
| 95 | MAP3K9 | 0.55138541 |
| 96 | AURKB | 0.54733008 |
| 97 | PBK | 0.53587230 |
| 98 | TAOK2 | 0.51266612 |
| 99 | MAP2K6 | 0.51180794 |
| 100 | CDK7 | 0.50714804 |
| 101 | TYK2 | 0.50109923 |
| 102 | TYRO3 | 0.50054383 |
| 103 | TESK2 | 0.49664454 |
| 104 | MAP3K6 | 0.49564411 |
| 105 | STK24 | 0.49416710 |
| 106 | MAP3K5 | 0.48774271 |
| 107 | PIM1 | 0.48702268 |
| 108 | MAP2K2 | 0.48537956 |
| 109 | ROCK1 | 0.47523100 |
| 110 | PRKAA2 | 0.47066370 |
| 111 | ICK | 0.46763147 |
| 112 | CDK4 | 0.46441717 |
| 113 | MAPK4 | 0.46321122 |
| 114 | TAOK1 | 0.46091205 |
| 115 | EPHA3 | 0.44327718 |
| 116 | CDK6 | 0.44244873 |
| 117 | ZAP70 | 0.43955285 |
| 118 | CAMK2G | 0.42971514 |
| 119 | MAPK12 | 0.42507043 |
| 120 | MAPKAPK2 | 0.41791787 |
| 121 | CHUK | 0.40480006 |
| 122 | PDGFRB | 0.40199413 |
| 123 | DYRK1B | 0.39989778 |
| 124 | LIMK1 | 0.39836111 |
| 125 | PAK1 | 0.39831983 |
| 126 | MST1R | 0.39406035 |
| 127 | CSK | 0.38718118 |
| 128 | PLK1 | 0.38163208 |
| 129 | PAK3 | 0.37123920 |
| 130 | ALK | 0.36941906 |
| 131 | PRKG2 | 0.36839057 |
| 132 | KSR2 | 0.36085766 |
| 133 | MAPK11 | 0.35637037 |
| 134 | SIK3 | 0.35414092 |
| 135 | RPS6KC1 | 0.33971814 |
| 136 | RPS6KL1 | 0.33971814 |
| 137 | MAPK7 | 0.33237030 |
| 138 | PDPK1 | 0.31920062 |
| 139 | PKN1 | 0.30946216 |
| 140 | RPS6KA2 | 0.29333182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.90394075 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.51271865 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.00254948 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.72781921 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42183865 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.39910250 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.28626365 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24016278 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.17078341 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.13221691 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93490185 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 1.90195415 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88879907 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.86157360 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.71762806 |
| 16 | Adherens junction_Homo sapiens_hsa04520 | 1.70855430 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66231960 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.64701607 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64639586 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.62306941 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.60245951 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.58774579 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.55337283 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54988859 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51371897 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.49636950 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.47227627 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41687966 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40997737 |
| 30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40573592 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33278242 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32936238 |
| 33 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.32311988 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 1.31650991 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.28941387 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.27173477 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.26614161 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 1.24323747 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.20147095 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19028521 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15550941 |
| 42 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15374086 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.14951638 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.14490426 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13561645 |
| 46 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.12912211 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12391561 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11135696 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10572403 |
| 50 | RNA transport_Homo sapiens_hsa03013 | 1.09588034 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 1.08527419 |
| 52 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06622553 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 1.05935235 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 1.05796794 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05035805 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 1.04392890 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04131329 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03843845 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 1.03316854 |
| 60 | Asthma_Homo sapiens_hsa05310 | 1.03185046 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97325726 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.95838055 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95025472 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.94861379 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93501582 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93152726 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.91946159 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90059604 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88942440 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 0.88108993 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87061968 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.85786115 |
| 73 | Hepatitis B_Homo sapiens_hsa05161 | 0.85670550 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84629207 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83315521 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81951662 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81298091 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81038418 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80941392 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.80709718 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80699959 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80320101 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76627484 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75701217 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74497086 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74158775 |
| 87 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73929495 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.73698729 |
| 89 | Spliceosome_Homo sapiens_hsa03040 | 0.72247169 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.72230455 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71786836 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71242811 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70248109 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.69721917 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69668408 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68685532 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68285188 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.68256854 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68046495 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.67404378 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66685690 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.65399223 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65325739 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63540606 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63149417 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62825742 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62796991 |
| 108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60319889 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60198591 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60025576 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57528075 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57286220 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56784012 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55858601 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55505094 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55494898 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54780747 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54635758 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54613114 |
| 120 | Malaria_Homo sapiens_hsa05144 | 0.54603956 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53885423 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53650245 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53481111 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.53348094 |
| 125 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51263020 |
| 126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51131482 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50256168 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50115801 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48956663 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47780216 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47111113 |
| 132 | Influenza A_Homo sapiens_hsa05164 | 0.45538132 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45537484 |
| 134 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45167664 |
| 135 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44617338 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44460923 |
| 137 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44042574 |
| 138 | Melanoma_Homo sapiens_hsa05218 | 0.43453206 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43441183 |
| 140 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40905565 |
| 141 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40659448 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40226758 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39072832 |
| 144 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38312493 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.36840373 |
| 146 | Phagosome_Homo sapiens_hsa04145 | 0.36563484 |
| 147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36435769 |

